Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07393971 · ClinicalTrials.gov registry record · NA
Development of a Real-time Controller to Estimate Walking Performance Using a Bilateral Ankle Exoskeleton
A NA study, sponsored by University of Nebraska.
- Not yet
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT07393971: Clinical Trial NA study, sponsored by University of Nebraska.
NCT07393971 is a NA study that has not yet begun recruiting, run by University of Nebraska. The registered enrollment target is 6 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07393971, a NA study, has not yet begun recruiting, sponsored by University of Nebraska.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
This study is developing and testing a new controller for a robotic ankle exoskeleton (Biomotum) that can adjust itself in real time to better support people while they walk. The system learns how each person moves and automatically changes the amount and timing of assistance to make walking feel easier and more efficient. By using information from the person wearing the device, the exoskeleton can quickly find the level of support that works best for them. The long-term goal is to create personalized walking assistance that can help people with mobility limitations move more comfortably and with less effort.
Primary Outcome
Device feasibility will be evaluated by the successful real-time operation of the robotic ankle exoskeleton and adaptive controller during treadmill walking. Feasibility is defined as the controller's ability to continuously generate, update, and apply assistive torque in real time based on incoming biomechanical and physiological data without system failure, interruption, or safety-related termination. Successful operation will be confirmed by continuous controller function and synchronized dat
Interventions
- DEVICE Adaptive Torque Control System for Ankle Exoskeleton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2026-06-01 |
| Est. Completion | 2026-12 |
| Phase | NA |
What is known before NCT07393971 opens enrollment
NCT07393971 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Adaptive Torque Control System for Ankle Exoskeleton is the first listed.
NCT07393971 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07393971 about?
NCT07393971 is a clinical study titled "Development of a Real-time Controller to Estimate Walking Performance Using a Bilateral Ankle Exoskeleton". This study is developing and testing a new controller for a robotic ankle exoskeleton (Biomotum) that can adjust itself in real time to better support people while they walk. The system learns how each person moves and automatically changes the amount and timing of assistance to make walking feel ea...
What is the current status of trial NCT07393971?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 6 participants. The study started on 2026-06-01. Estimated completion is 2026-12.
What interventions are being tested in trial NCT07393971?
The interventions under investigation include: Adaptive Torque Control System for Ankle Exoskeleton (DEVICE).
Who is sponsoring clinical trial NCT07393971?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07393971's enrollment target sits among peer trials
6 1983rd of 2000 higher than 13 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI